Page 31 - nh Enzyme-Report-6x9-Updated-v2_Neat

diagnosis, the median
survival rate is just over three
years.

Conventional medicine has
little to offer pulmonary
fibrosis sufferers except
immune suppressive
agents to slow the lung
inflammation and related
scarring like corticosteroids,
or a lung transplant.

However, systemic
proteolytic enzymes shows
promise in helping those
with pulmonary fibrosis
as they help modulate
the inflammation response cycle, break down excess scar tissue,
prevent and break down blood clots, and stimulate microphages to
clean the blood of debris.

Cystic Fibrosis

Cystic fibrosis (CF) is a genetic disorder most noted for its
dangerous impact on lungs, with frequent lung infections leading
to fibrotic scarring and difficulty breathing. However, the disorder
usually appears with exceptionally sticky mucus blocking pancreas
ducts, bile ducts, intestines and bronchi in the lungs.

Since CF blocks the release of pancreatic enzymes, digestive
enzyme therapy is critically important for those with the disease.
Without digestive enzyme supplementation, those with CF may fail
to gain weight and suffer from malnutrition.

The Healthy Back Institute® • 29